Health In Tech Extends Executive Lock-Up Period to June 2026

Written by Emily J. Thompson, Senior Investment Analyst

Updated: Dec 02 2025

0mins

Health In Tech announced that its executive management team, vice presidents across functions, and Board of Directors have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional six months beyond the original twelve-month lock-up established at the time of the company's final prospectus issued in connection with its initial public offering on December 20, 2024. Under this voluntary extension, all shares held by Health In Tech's current executive officers and Board of Directors will remain restricted from sale or transfer until June 20, 2026.

HIT

$1.42+Infinity%1D

Analyst Views on HIT

Wall Street analysts forecast HIT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HIT is 4.50 USD with a low forecast of 4.50 USD and a high forecast of 4.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Analyst Rating

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 1.480

Low

4.50

Averages

4.50

High

4.50

Current: 1.480

Low

4.50

Averages

4.50

High

4.50

Maxim

NULL -> Buy

initiated

$2.50

2025-06-26

Reason

Maxim

Price Target

$2.50

AI Analysis

2025-06-26

initiated

NULL -> Buy

Reason

Maxim initiated coverage of Health In Tech with a Buy rating and $2.50 price target.

Maxim

Buy

initiated

$2.50

2025-06-26

Reason

Maxim

Price Target

$2.50

2025-06-26

initiated

Buy

Reason

Maxim initiated coverage of Health In Tech with a Buy rating and $2.50 price target. The company operates in a multi-billion-dollar market, with mostly recurring revenue and high gross margin, and the firm expects growth from new services and expansion into the mid-size employer market, the analyst tells investors in a research note. Maxim adds that its rating reflects its positive view of the large market opportunity, competitive advantages, and multiple growth initiatives.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HIT

Unlock Now

About HIT

Health In Tech, Inc. is an Insurtech platform company backed by third-party artificial intelligence technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.